With so many scientific reports on animals, Effepharm decided to conduct our own clinical study on Uthever®.
Our clinical study would start from:
(1) Safety assessment
(2) Anti-aging
(3) Boosting energy and increasing endurance

The clinical study on Uthever® is registered in the US and WHO’s official clinical registry system and displayed on the websites to the public.

Title: Evaluate the Efficacy and Safety of Uthever NMN(Nicotinamide Mononucleotide, a Form of Vitamin B3)

Official Title: A Multicentre, Randomized, Double Blind, Parallel Design, Placebo Controlled Study to Evaluate the Efficacy and Safety of Uthever® (NMN), an Orally Administered Supplementation in Middle Aged and Older Adults.

US register ID: NCT04228640

Study Type: Interventional  (Clinical Trial)

Estimated Enrollment: 66 participants

Allocation: Randomized

Intervention Model: Parallel Assignment

Intervention Model Description: A Multicenter, Randomized, Double-Blind, Placebo-Controlled

Primary Purpose: Prevention

To assess its safety, physical examination, blood biochemistry test, BMI, HOMA will be performed at baseline and end of the study. Blood cellular NAD+ and NADH concentration in serum will de determined to confirm its ability to increase NAD level in human body.

Effepharm is proud to be the first and the only NMN Manufacturer in the world to conduct clinical trials. The clinical study on Uthever® is the largest scale in the world according to WHO’s clinical database.